Isomorphic Labs raises a $2.1 billion Series B
On 12 May 2026 Isomorphic Labs announced a $2.1 billion Series B round led by Thrive Capital, money the company says will scale its business globally and push its drug candidate pipeline forward.
Total 3 · Clear filters
On 12 May 2026 Isomorphic Labs announced a $2.1 billion Series B round led by Thrive Capital, money the company says will scale its business globally and push its drug candidate pipeline forward.
On 12 February 2026 Anthropic announced a $30 billion Series G at a $380 billion post-money valuation, led by GIC and Coatue, with run-rate revenue of $14 billion and Claude Code alone above $2.5 billion.
Anthropic announced a $13 billion Series F on 2 September 2025 at a $183 billion post-money valuation, led by ICONIQ, as run-rate revenue passed $5 billion and Claude Code passed $500 million.